Atlas Trials

CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma

Clinical trial NCT06101381 · RECRUITING

Trial details

NCT number
NCT06101381
Sponsor
University of Sao Paulo
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Leukemia, Acute LymphoblasticLymphoma, Non-Hodgkin
Start date
2024-03-21
Primary completion
2028-12-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.